Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Lazarus

Showing results (641-650 of 1,048) with videos related to

Pageof 105
Sort By:
Journal of the American Chemical Society|September 9, 2011
Rational domain swaps decipher programming in fungal highly reducing polyketide synthases and resurrect an extinct metaboliteKatja M Fisch, Walid Bakeer, Ahmed A Yakasai, et al.
Kidney International|June 3, 1999
Peritoneal dialysis adequacy: a model to assess feasibility with various modalitiesJ A Diaz-Buxo, F A Gotch, T I Folden, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1983
Intensive melphalan chemotherapy and cryopreserved autologous bone marrow transplantation for the treatment of refractory cancerH M Lazarus, R H Herzig, J Graham-Pole, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1992
High-dose carmustine, etoposide, and cisplatin and autologous bone marrow transplantation for relapsed and refractory lymphomaH M Lazarus, P Crilley, N Ciobanu, et al.
Surgical Infections|September 22, 2007
A six-year descriptive study of hospital-associated infection in trauma patients: demographics, injury features, and infection patternsHarrison M Lazarus, Jolene Fox, James F Lloyd, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 2, 2016
Allogeneic Hematopoietic Cell Transplantation as Curative Therapy for Patients with Non-Hodgkin Lymphoma: Increasingly Successful Application to Older PatientsTimothy S Fenske, Mehdi Hamadani, Jonathon B Cohen, et al.
The Journal of Trauma|August 13, 2005
Trauma patient hospital-associated infections: risks and outcomesHarrison M Lazarus, Jolene Fox, John P Burke, et al.
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|January 1, 1993
Initial clinical experience with a new model of mass transfer for peritoneal dialysisP J Walker, N M Juhasz, T E Taber, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 14, 1997
A phase II multicenter trial of high-dose sequential chemotherapy and peripheral blood stem cell transplantation as initial therapy for patients with high-risk non-Hodgkin's lymphomaD P Schenkein, D Roitman, K B Miller, et al.
British Journal of Haematology|December 24, 2005
Randomised comparison of two B-cell purging protocols for patients with B-cell non-Hodgkin lymphoma: in vivo purging with rituximab versus ex vivo purging with CliniMACS CD34 cell enrichment deviceWillem J van Heeckeren, Jennifer Vollweiler, Pingfu Fu, et al.
Pageof 105

Showing results (641-650 of 1,048) with videos related to

Sort By:
Pageof 105
Journal of the American Chemical Society|September 9, 2011
Rational domain swaps decipher programming in fungal highly reducing polyketide synthases and resurrect an extinct metaboliteKatja M Fisch, Walid Bakeer, Ahmed A Yakasai, et al.
Kidney International|June 3, 1999
Peritoneal dialysis adequacy: a model to assess feasibility with various modalitiesJ A Diaz-Buxo, F A Gotch, T I Folden, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1983
Intensive melphalan chemotherapy and cryopreserved autologous bone marrow transplantation for the treatment of refractory cancerH M Lazarus, R H Herzig, J Graham-Pole, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1992
High-dose carmustine, etoposide, and cisplatin and autologous bone marrow transplantation for relapsed and refractory lymphomaH M Lazarus, P Crilley, N Ciobanu, et al.
Surgical Infections|September 22, 2007
A six-year descriptive study of hospital-associated infection in trauma patients: demographics, injury features, and infection patternsHarrison M Lazarus, Jolene Fox, James F Lloyd, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 2, 2016
Allogeneic Hematopoietic Cell Transplantation as Curative Therapy for Patients with Non-Hodgkin Lymphoma: Increasingly Successful Application to Older PatientsTimothy S Fenske, Mehdi Hamadani, Jonathon B Cohen, et al.
The Journal of Trauma|August 13, 2005
Trauma patient hospital-associated infections: risks and outcomesHarrison M Lazarus, Jolene Fox, John P Burke, et al.
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|January 1, 1993
Initial clinical experience with a new model of mass transfer for peritoneal dialysisP J Walker, N M Juhasz, T E Taber, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 14, 1997
A phase II multicenter trial of high-dose sequential chemotherapy and peripheral blood stem cell transplantation as initial therapy for patients with high-risk non-Hodgkin's lymphomaD P Schenkein, D Roitman, K B Miller, et al.
British Journal of Haematology|December 24, 2005
Randomised comparison of two B-cell purging protocols for patients with B-cell non-Hodgkin lymphoma: in vivo purging with rituximab versus ex vivo purging with CliniMACS CD34 cell enrichment deviceWillem J van Heeckeren, Jennifer Vollweiler, Pingfu Fu, et al.
Pageof 105